{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:54:12Z","timestamp":1791028452133,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clbc.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:15:29Z","timestamp":1789139729000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Immunomodulatory Effect of Various Anesthetic Factors and Techniques on Patients Undergoing Breast Cancer Surgery: A Systematic Review and Meta-analyses of RCTs"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4665-4443","authenticated-orcid":false,"given":"Paraskevas","family":"Mavropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-6418","authenticated-orcid":false,"given":"Georgios","family":"Konstantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Tsaousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Baka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varvara","family":"Ziaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-7082","authenticated-orcid":false,"given":"Vasilis-Spyridon","family":"Tseriotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-9295","authenticated-orcid":false,"given":"Zoi","family":"Tsimtsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssa","family":"Pourzitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clbc.2026.09.002_bib0001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/GRF.0000000000000239","article-title":"Breast cancer epidemiology and risk factors","volume":"59","author":"Rojas","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.clbc.2026.09.002_bib0002","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2024"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0003","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"Surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res"},{"issue":"14","key":"10.1016\/j.clbc.2026.09.002_bib0004","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","article-title":"AACR centennial series: the biology of cancer metastasis: historical perspective","volume":"70","author":"Talmadge","year":"2010","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.clbc.2026.09.002_bib0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archsurg.141.11.1132","article-title":"Cell response to surgery","volume":"141","author":"Choileain","year":"2006","journal-title":"Arch Surg"},{"issue":"21","key":"10.1016\/j.clbc.2026.09.002_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111378","article-title":"Postoperative natural killer cell dysfunction: the prime suspect in the case of metastasis following curative cancer surgery","volume":"22","author":"Market","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clbc.2026.09.002_bib0007","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archsurg.135.10.1141","article-title":"Apoptosis and surgical trauma dysregulated expression of death and survival factors on peripheral lymphocytes","volume":"135","author":"Delogu","year":"2000","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.aat.2015.03.002","article-title":"Clinical implication of perioperative inflammatory cytokine alteration","volume":"53","author":"Hsing","year":"2015","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1016\/j.clbc.2026.09.002_bib0009","first-page":"678","article-title":"Anesthesia and the immune response","volume":"68","author":"Bruce","year":"1981","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.002_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1172\/JCI110303","article-title":"Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors","volume":"68","author":"Shapiro","year":"1981","journal-title":"J Clin invest"},{"key":"10.1016\/j.clbc.2026.09.002_bib0011","article-title":"Systemic immune effects of anesthetics and their intracellular targets in tumors","volume":"9","author":"Luan","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/s12871-018-0543-3","article-title":"Effect of Propofol on breast cancer cell, the immune system, and patient outcome","volume":"18","author":"Li","year":"2018","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2011.10.006","article-title":"Propofol reduces MMPs expression by inhibiting NF-\u03bab activity in human MDA-MB-231 cells","volume":"66","author":"Li","year":"2012","journal-title":"Biomed Pharmacother"},{"issue":"9\u201310","key":"10.1016\/j.clbc.2026.09.002_bib0014","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.lfs.2007.12.014","article-title":"Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo","volume":"82","author":"Wang","year":"2008","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0015","article-title":"Distinct effects of general anesthetics on lung metastasis mediated by IL-6\/JAK\/STAT3 pathway in mouse models","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.002_bib0016","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00000542-200610000-00008","article-title":"Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?","volume":"105","author":"Exadaktylos","year":"2006","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.clbc.2026.09.002_bib0017","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12630-015-0523-8","article-title":"Les techniques d\u2019anesth\u00e9sie et d\u2019analg\u00e9sie lors d\u2019une chirurgie de cancer primitif peuvent-elle affecter la r\u00e9currence ou la m\u00e9tastase?","volume":"63","author":"Byrne","year":"2016","journal-title":"Can J Anesth"},{"key":"10.1016\/j.clbc.2026.09.002_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.clbc.2026.09.002_bib0019","unstructured":"Mendeley Ltd. Mendeley Reference Manager; 2026. Available at: https:\/\/www.mendeley.com\/."},{"key":"10.1016\/j.clbc.2026.09.002_bib0020","series-title":"WebPlotDigitizer - Copyright 2010-2024 Ankit Rohatgi","author":"Rohatgi","year":"2026"},{"key":"10.1016\/j.clbc.2026.09.002_bib0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and Standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clbc.2026.09.002_bib0022","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.09.002_bib0023","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for glass\u2019s estimator of effect size and related estimators","volume":"6","author":"Hedges","year":"1981","journal-title":"J Educ Stat"},{"key":"10.1016\/j.clbc.2026.09.002_bib0024","unstructured":"Posit team. RStudio: Integrated Development Environment for R. Posit software, PBC. 2025. Available at: http:\/\/www.posit.co\/. Accessed: May 4, 2026."},{"issue":"5","key":"10.1016\/j.clbc.2026.09.002_bib0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/anae.14207","article-title":"The effect of anaesthetic technique during primary breast cancer surgery on neutrophil\u2013lymphocyte ratio, platelet\u2013lymphocyte ratio and return to intended oncological therapy","volume":"73","author":"N\u00ed Eochag\u00e1in","year":"2018","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.002_bib0026","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1658-354X.121043","article-title":"Paravertebral block can attenuate cytokine response when it replaces general anesthesia for cancer breast surgeries","volume":"7","author":"Sultan","year":"2013","journal-title":"Saudi J Anaesth"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0027","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.21037\/gs-21-343","article-title":"A randomised trial: effects of different anesthesia methods on early perioperative pain sensitivity and cellular immune function in patients undergoing radical mastectomy","volume":"10","author":"Li","year":"2021","journal-title":"Gland Surg"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.002_bib0028","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjsurg.2020.03.008","article-title":"Effect of pectoral nerve block type II under general anesthesia on the immune function of patients with breast cancer","volume":"220","author":"Cui","year":"2020","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.002_bib0029","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/aas.13745","article-title":"Serum NETosis expression and recurrence risk after regional or volatile anaesthesia during breast cancer surgery: a pilot, prospective, randomised single-blind clinical trial","volume":"65","author":"Aghamelu","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26273-z","article-title":"Benefits in radical mastectomy protocol: a randomized trial evaluating the use of regional anesthesia","volume":"8","author":"Matsumoto","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.002_bib0031","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bja.2020.05.003","article-title":"Neutrophil extracellular trapping and angiogenesis biomarkers after intravenous or inhalation anaesthesia with or without intravenous lidocaine for breast cancer surgery: a prospective, randomised trial","volume":"125","author":"Galo\u0219","year":"2020","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.002_bib0032","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/ALN.0000000000002382","article-title":"Effect of equipotent doses of propofol versus sevoflurane anesthesia on regulatory T cells after breast cancer surgery","volume":"129","author":"Oh","year":"2018","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.clbc.2026.09.002_bib0033","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7150\/ijms.20064","article-title":"The effects of perioperative anesthesia and analgesia on immune function in patients undergoing breast cancer resection: a prospective randomized study","volume":"14","author":"Cho","year":"2017","journal-title":"Int J Med Sci"},{"issue":"10","key":"10.1016\/j.clbc.2026.09.002_bib0034","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3346\/jkms.2015.30.10.1503","article-title":"Effect of propofol and desflurane on immune cell populations in breast cancer patients: a randomized trial","volume":"30","author":"Woo","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clbc.2026.09.002_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1401910","article-title":"The impact of inhalation versus total intravenous anesthesia on the immune status in patients undergoing breast cancer surgery: a double-blind randomized clinical trial (TeMP)","volume":"14","author":"Kadantseva","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4064-8","article-title":"The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis","volume":"18","author":"Lim","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.002_bib0037","doi-asserted-by":"crossref","first-page":"489","DOI":"10.25259\/jmr_2382_23","article-title":"Management of T cell responses by anesthetic drugs-propofol & isoflurane in perioperative breast cancer patients: a prospective hospital-based study","volume":"160","author":"Saha","year":"2024","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.002_bib0038","first-page":"146","article-title":"Effect of lidocaine infusion during general anesthesia on neutrophil-lymphocyte-ratio in breast cancer patients candidate for mastectomy; a clinical trial","volume":"1","author":"Memari","year":"2016","journal-title":"J Cell Mol Anesthesia"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.002_bib0039","doi-asserted-by":"crossref","first-page":"599","DOI":"10.21037\/gs-22-134","article-title":"Effect of intravenous lidocaine infusion on perioperative cellular immunity and the quality of postoperative recovery in breast cancer patients: a randomized controlled trial","volume":"11","author":"Wei","year":"2022","journal-title":"Gland Surg"},{"key":"10.1016\/j.clbc.2026.09.002_bib0040","article-title":"S-ketamine attenuates inflammatory effect and modulates the immune response in patients undergoing modified radical mastectomy: a prospective randomized controlled trial","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.clbc.2026.09.002_bib0041","first-page":"487","article-title":"Effect of equipotent doses of propofol and sevoflurane on endoplasmic reticulum stress during breast cancer surgery","volume":"75","author":"Oh","year":"2022","journal-title":"Korean J Anesthesiol"},{"issue":"21","key":"10.1016\/j.clbc.2026.09.002_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218011","article-title":"CD4 T helper cell subsets and related human immunological disorders","volume":"21","author":"Zhu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clbc.2026.09.002_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.972021","article-title":"Roles of CD4+ T cells as mediators of antitumor immunity","volume":"13","author":"Kravtsov","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.002_bib0044","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.clbc.2026.09.002_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.002_bib0046","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","article-title":"Tumour-infiltrating lymphocytes: from prognosis to treatment selection","volume":"128","author":"Brummel","year":"2023","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.002_bib0047","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.21037\/jtd-21-878","article-title":"Propofol decreases CD8+ T cells and sevoflurane increases regulatory T cells after lung cancer resection: a randomized controlled trial","volume":"13","author":"Yamaguchi","year":"2021","journal-title":"J Thorac Dis"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.002_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082323","article-title":"The function of NK cells in tumor metastasis and NK cell-based immunotherapy","volume":"15","author":"Yu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2026.09.002_bib0049","first-page":"115","article-title":"The effect of regional vs. GENERAL anesthesia on THE immune response in breast cancer surgery: a narrative review of THE literature","volume":"61","author":"Vrbanovi\u0107 Mijatovi\u0107","year":"2022","journal-title":"Acta Clin Croat"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratislava Med J"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.clbc.2026.09.002_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006624","article-title":"Imbalance in the game of T cells: what can the CD4\/CD8 T-cell ratio tell us about HIV and health?","volume":"13","author":"McBride","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clbc.2026.09.002_bib0053","unstructured":"Bruno G, Saracino A, Monno L, Angarano G The Revival of an \u201cOld\u201d Marker: CD4\/CD8 Ratio. Available at: www.permanyer.com."},{"issue":"6","key":"10.1016\/j.clbc.2026.09.002_bib0054","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/djac053","article-title":"CD4\/CD8 Ratio and cancer risk among adults with HIV","volume":"114","author":"Castilho","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.clbc.2026.09.002_bib0055","first-page":"800","article-title":"Correlation of peripheral blood CD4\/CD8 ratio with efficacy and prognosis in patients with non-small cell lung cancer receiving PD-1\/PD-L1 inhibitors","volume":"35","author":"Li","year":"2025","journal-title":"J Coll Phys Surgeon Pak"},{"issue":"10","key":"10.1016\/j.clbc.2026.09.002_bib0056","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"Il-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7090","key":"10.1016\/j.clbc.2026.09.002_bib0057","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0058","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.clbc.2026.09.002_bib0059","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.11143","article-title":"Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis","volume":"48","author":"Nakahara","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.002_bib0060","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.clbc.2026.09.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9056173","article-title":"Prospects of IL-2 in cancer immunotherapy","volume":"2018","author":"Choudhry","year":"2018","journal-title":"Biomed Res Int"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.002_bib0062","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2026.09.002_bib0063","article-title":"Neutrophil extracellular traps: new players in cancer research","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0064","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"02","key":"10.1016\/j.clbc.2026.09.002_bib0066","doi-asserted-by":"crossref","first-page":"048","DOI":"10.1055\/s-0043-1768166","article-title":"The role of the matrix metalloproteinase-9 gene in tumor development and metastasis: a narrative review","volume":"10","author":"Kalali","year":"2023","journal-title":"Glob Med Genet"},{"key":"10.1016\/j.clbc.2026.09.002_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front Oncol"},{"issue":"MAR","key":"10.1016\/j.clbc.2026.09.002_bib0068","article-title":"The HPA - immune axis and the immunomodulatory actions of glucocorticoids in the brain","volume":"5","author":"Bellavance","year":"2014","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.002_bib0069","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bjae.2020.04.006","article-title":"Anaesthesia, analgesia, and the surgical stress response","volume":"20","author":"Cusack","year":"2020","journal-title":"BJA Educ"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.002_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.htct.2020.03.003","article-title":"Implications of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response","volume":"43","author":"Aguilar-Nascimento","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"10.1016\/j.clbc.2026.09.002_bib0071","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/tmrv.2002.31463","article-title":"Possible mechanisms of allogeneic blood transfusion-associated postoperative infection","volume":"16","author":"Vamvakas","year":"2002","journal-title":"Transfus Med Rev"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.002_bib0072","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/bja\/aet068","article-title":"Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions","volume":"110","author":"Cata","year":"2013","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.clbc.2026.09.002_bib0073","first-page":"457","article-title":"Mechanisms of transfusion-associated immunosuppression","volume":"1","author":"Blajchman","year":"1994","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.002_bib0074","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10151-013-1014-y","article-title":"Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival","volume":"17","author":"Ghinea","year":"2013","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.clbc.2026.09.002_bib0075","unstructured":"Heike Rittner C, Mirja Plein L, Rittner HL. Opioids and the immune system-friend or foe LINKED ARTICLES. 2017. Published online. doi:10.1111\/bph.v175.14\/issuetoc."},{"issue":"4","key":"10.1016\/j.clbc.2026.09.002_bib0076","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections","volume":"6","author":"Roy","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.002_bib0077","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11864-023-01091-2","article-title":"Effects of opioids on immune and endocrine function in patients with cancer pain","volume":"24","author":"Bradley","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"suppl 2)","key":"10.1016\/j.clbc.2026.09.002_bib0078","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1998","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.002_bib0079","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2026.09.002_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.637504","article-title":"Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer","volume":"11","author":"Pu","year":"2021","journal-title":"Front Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:19:25Z","timestamp":1791026365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":80,"alternative-id":["S1526820926001655"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.09.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Immunomodulatory Effect of Various Anesthetic Factors and Techniques on Patients Undergoing Breast Cancer Surgery: A Systematic Review and Meta-analyses of RCTs","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}